UPC CFI 504/2023
Jan 2, 2024·EP1970677 · Intravenous infusion system with dosing device
- Case details
- StatusCase Closed (Settled)ActionInfringementCategoryMain infringement action
- Parties
- Claimants
- F. Hoffmann-La Roche AGOperating co.
Representatives- Christof Augenstein-Kather Augenstein
- Sophie Prudent-Kather Augenstein
- Katharina Brandt-Kather Augenstein
- Thomas Kronbergersupporting-Grünecker Patent- und Rechtsanwälte PartGmbH
Respondents- Tandem Diabetes Care, Inc.Operating co.
- Tandem Diabetes Care Europe B.V.Operating co.
- VitalAire GmbHOperating co.
- Dinno Santé s.a.i.Operating co.
- Air Liquide Healthcare Nederland B.V.Operating co.
- Rubin Medical ApSOperating co.
Representatives- Roland Küppers-Taylor Wessing
- Alexander Rubusch-Taylor Wessing
- Christine Kanz-Hoyng Rokh Monegier
- Tung-Gia du-Hoyng Rokh Monegier
- Charlotte Garnitsch-Taylor Wessing
- Wim Maas-Taylor Wessing
- Iris van der Heijdt-Taylor Wessing
- Pauline Springorum-Taylor Wessing
- Patrick van Ginneken-Algemeen Octrooi- en Merkenbureau B.V.
- Konstantin Schallmoser-Bonabry
- Alexander Harguth-Bonabry
- Carl-Alexander Dinges-Bonabry
- Division
- Dusseldorf LD
- Technology
- InstrumentsMeasurement · Medical technology
- Language
- German
| Infringement found | Median days to first decision | |
|---|---|---|
| All UPC | 53% (62/117) | 124 |
| Dusseldorf LD | Locked | Locked |
| Judge Ronny Thomas | Locked | Locked |
| Judge Jule Schumacher | Locked | Locked |
| Judge Margot Kokke | Locked | Locked |
| Judge Christoph Schober | Locked | Locked |
At the UPC: Roche Group (29 cases)·Tandem Diabetes Care Group (18 cases)
This dispute contains 8 other proceedings
CC 20972/2024·CC 21542/2024·UPC APP 11294/2025·UPC APP 23079/2025·UPC APP 28226/2025 and 3 more
Start a free trial to see how each one ended.
More cases: Dusseldorf LD·2023
- 2025-06-02Application RoP 365Public
Summary: The court confirmed a partial settlement between the claimants (Roche) and defendants 1 and 2 (Tandem Diabetes Care Inc. and Tandem Diabetes Care Europe B.V.) pursuant to Rule 365.1 RoP. The details of the settlement are confidential. Proceedings against defendants 3 to 6 continue. Each settling party bears its own costs.
Show the legal issues (3)
- Settlement confirmation (Rule 365.1 RoP)
- Confidentiality of settlement terms (Rule 365.2 RoP)
- Partial settlement
| Document title | Date | Public |
|---|---|---|
| Case Closure Formal Check | 2025-07-25 | Not public |
| Headnote-and-Keywords | 2025-06-30 | Not public |
| Outcome of the Order | 2025-06-30 | Not public |
| Zurückweisung Anträge auf Rückerstattung | 2025-06-30 | Public |
| Outcome of the Order | 2025-06-30 | Not public |
| Zurückweisung Anträge auf Rückerstattung | 2025-06-30 | Public |
| Receipt | 2025-06-24 | Not public |
| 2025-06-24_LD_Duesseldorf_Antrag_Rueckerstattung_Gerichtsgebuehren_signiert.pdf | 2025-06-24 | Not public |
| Outcome of the Order | 2025-06-20 | Not public |
| Schließung des Workflows | 2025-06-20 | Public |
Roche and Roche Diabetes Care sued Tandem Diabetes Care and other defendants at the Düsseldorf Local Division for infringement of EP 1 970 677 B1 (intravenous infusion system with dosing device). The action against Tandem Diabetes Care Inc. and Tandem Diabetes Care Europe B.V. settled on confidential terms in June 2025, while proceedings against the remaining defendants (VitalAire, Dinno Santé, Air Liquide Healthcare Nederland) continue.
No accepted arguments captured.
No rejected arguments captured.
Browse other cases on this principle.